Latest mutations News | Page 2

Gene-editing tool helps target small cancer-linked mutations
Universal siRNA Covid treatment shows promise in lab
From ‘good’ old Kiwi farm dog to ‘great’
Enhertu demonstrated clinically meaningful progression-free survival and overall survival across multiple HER2-expressing advanced solid tumours in DESTINY-PanTumor02 Phase II trial
WHO issues rapid communication on use of targeted next-generation sequencing for diagnosis of drug-resistant tuberculosis
Increased efficiency, precision and reliability in DNA editing
Treatment advances providing new hope to patients
Ludwig Harvard study uncovers role of ultraviolet radiation in the development of a rare leukemia in the skin
Tagrisso achieved unprecedented survival in early-stage EGFR-mutated lung cancer, with 88% of patients alive at five years in ADAURA Phase III trial
Lynparza and Imfinzi combination reduced risk of disease progression or death by 37% vs. chemotherapy and bevacizumab in patients with advanced ovarian…
A Novel High-Throughput Method for Screening Protein-Secreting Microbial Strains
Mater launches trial of Australian-first flu vaccine
Study aims to reveal hidden causes of miscarriage
Baylor College of Medicine receives NIH funding to study somatic mosaicism
Cancer may lurk in ‘normal looking’ skin
How DNA Repair Can Go Wrong and Lead to Disease
Researchers Identify a New Genetic Culprit in Canine Bladder Cancers
Stay CALM when heart skips beat
Novel approach prevents liver damage in animal models of Alagille syndrome
Lynparza and Imfinzi combination improved progression-free survival in newly diagnosed patients with advanced ovarian cancer without tumour BRCA mutations in DUO-O Phase III trial
UOW scientist secures funding from The Michael J. Fox Foundation and Shake It Up Australia
Chief Health Officer Update 31 March
Chief Health Officer Update 24 March
Cryo-electron Microscopy Captures Structure of Protein Pump
Obesity may exacerbate breast cancer risk in women with BRCA mutations
AI helps Manchester scientists to understand congenital heart defects
New way to study molecular drivers of cancer
Chief Health Officer Update 17 March
Patrys’ says preclinical data supports synthetic lethality mechanism
Major advance in super-resolution fluorescence microscopy
Chief Health Officer Update 10 March
Wheat’s ancient roots of viral resistance
Enhertu showed clinically meaningful and durable responses across multiple HER2-expressing tumour types in DESTINY-PanTumor02 Phase II trial
Chief Health Officer Update 3 March
Differences in animal biology can affect cancer drug development
Big impact of rare disease research
Chief Health Officer Update 24 February
New molecule discovery linked to bone disease
An avian flu outbreak is spreading to mammals – what is the risk to humans?
Weill Cornell Medicine grants to advance lymphoma research
Bioinformatics training workshops to strengthen genomic surveillance successfully completed
Protein droplets may cause many types of genetic disease
Disease detectives: new frontier in genetic mutations
Deer carry SARS-CoV-2 variants that are extinct in humans
Lymphoma mutation yields super-competitive immune cells
Chief Health Officer Update 20 January
Cancer biology: Some cancer cells can lose their capability to migrate
Chloroplast from father